Redsense Medical AB (ST:REDS) — Stock Price

Skr4.00 SEK
▲ 0.25% today

Redsense Medical AB (ST:REDS) is currently trading at Skr4.00 SEK, up 0.25% today. Over the past 52 weeks, shares have ranged between Skr2.54 and Skr5.70. This page tracks Redsense Medical AB's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see REDS company net worth.

Redsense Medical AB (REDS) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Redsense Medical AB's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.

Redsense Medical AB Income Statement — Revenue, Profit & Earnings by Year

Redsense Medical AB's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue Skr28.18 Million Skr24.97 Million Skr14.34 Million Skr9.36 Million Skr14.44 Million
Cost of Revenue Skr10.10 Million Skr11.84 Million Skr3.08 Million Skr-1.04 Million Skr4.48 Million
Gross Profit Skr18.08 Million Skr13.13 Million Skr11.26 Million Skr10.40 Million Skr9.96 Million
Research & Development
SG&A Skr15.08 Million Skr10.45 Million
Total Operating Expenses Skr27.97 Million Skr30.03 Million Skr24.55 Million Skr21.35 Million Skr22.57 Million
Operating Income Skr209.00K Skr-5.07 Million Skr-10.21 Million Skr-11.99 Million Skr-8.12 Million
EBITDA
EBIT
Interest Expense Skr36.00K Skr33.00K Skr102.00K Skr51.00K Skr38.30K
Income Before Tax Skr342.00K Skr-4.51 Million Skr-8.76 Million Skr-7.97 Million Skr-9.03 Million
Income Tax Expense
Net Income Skr342.00K Skr-4.51 Million Skr-8.76 Million Skr-7.97 Million Skr-9.03 Million

Redsense Medical AB Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Redsense Medical AB's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets Skr41.80 Million Skr26.50 Million Skr30.73 Million Skr43.25 Million Skr78.70 Million
Total Current Assets Skr27.99 Million Skr13.24 Million Skr18.01 Million Skr32.94 Million Skr70.73 Million
Cash & Equivalents
Short-term Investments Skr6.91 Million Skr21.97 Million Skr36.02 Million
Net Receivables Skr6.10 Million Skr2.97 Million Skr4.93 Million Skr3.53 Million Skr2.09 Million
Inventory Skr4.02 Million Skr1.27 Million Skr742.00K Skr1.38 Million Skr2.34 Million
Property, Plant & Equipment
Goodwill
Total Liabilities Skr2.21 Million Skr3.41 Million Skr3.58 Million Skr5.76 Million Skr5.51 Million
Total Current Liabilities Skr2.21 Million Skr3.41 Million Skr3.58 Million Skr3.19 Million Skr5.51 Million
Long-term Debt Skr0.00 Skr2.57 Million Skr0.00
Net Debt
Total Stockholder Equity Skr39.58 Million Skr23.09 Million Skr27.15 Million Skr37.49 Million Skr73.20 Million
Retained Earnings Skr23.78 Million Skr8.13 Million Skr12.73 Million Skr-87.54 Million Skr-51.84 Million

Redsense Medical AB Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Redsense Medical AB generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow Skr-8.23 Million Skr-5.05 Million Skr-9.78 Million Skr-12.22 Million Skr17.23 Million
Capital Expenditures Skr611.00K Skr603.00K Skr2.46 Million Skr9.22 Million Skr37.08 Million
Free Cash Flow Skr-8.84 Million Skr-5.66 Million Skr-12.24 Million Skr-21.44 Million Skr-19.85 Million
Investing Cash Flow
Financing Cash Flow
Dividends Paid
Stock-Based Compensation
Depreciation Skr66.00K Skr62.00K
Change in Cash Skr8.39 Million Skr3.29 Million Skr-1.31 Million Skr-23.82 Million Skr18.85 Million

Redsense Medical AB Earnings History — EPS Actual vs. Analyst Estimates

Track Redsense Medical AB's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 26, 2026
Feb 19, 2026
Nov 19, 2025 -0.02
Aug 20, 2025 -0.11
May 28, 2025 -0.19
Feb 26, 2025 0.34
Nov 26, 2024 -0.20
Aug 29, 2024 0.04